Dexamethasone downregulated the expression of CSF 14-3-3β protein in mice with eosinophilic meningitis caused by Angiostrongylus cantonensis infection

Acta Tropica

Volumn 131, Issue 1, 2014, Pages 98-103

  Tsai, Hung Chin ^a,b   Lee, Bi Yao ^a,b   Yen, Chuan Min ^c   Wann, Shue Ren ^a,b   Lee, Susan Shin Jung ^a,b   Chen, Yao Shen ^a,b   Tai, Ming Hong ^d  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

14 3 3 protein; Angiostrongylus cantonensis; Blood brain barrier; Corticosteroid; Eosinophilic meningitis; Mice

Indexed keywords

14 3 3BETA PROTEIN; BRAIN PROTEIN; DEXAMETHASONE; UNCLASSIFIED DRUG;

BIOMARKER; GENE EXPRESSION; INFECTIOUS DISEASE; NEUROLOGY; PARASITIC DISEASE; PATHOLOGY; PROTEIN; RODENT;

ANGIOSTRONGYLIASIS; ANGIOSTRONGYLUS CANTONENSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIC MENINGITIS; MENINGITIS; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION;

PACIFIC ISLANDS; PACIFIC OCEAN; SOUTHEAST ASIA;

14-3-3Β PROTEIN; ANGIOSTRONGYLUS CANTONENSIS; BLOOD BRAIN BARRIER; CORTICOSTEROID; EOSINOPHILIC MENINGITIS; MICE;

14-3-3 PROTEINS; ANGIOSTRONGYLUS CANTONENSIS; ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; DEXAMETHASONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; GENE EXPRESSION; MENINGITIS; MICE; MICE, INBRED BALB C; SNAILS; STRONGYLIDA INFECTIONS;

EID: 84891785032     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2013.12.006     Document Type: Article

References (41)

1. Aksamit A.J. Cerebrospinal fluid 14-3-3 protein: variability of sporadic Creutzfeldt-Jakob disease, laboratory standards, and quantitation. Arch. Neurol. 2003, 60:803-804.
2. Assossou O., Besson F., Rouault J.P., Persat F., Ferrandiz J., Mayençon M., Peyron F., Picot S. Characterization of an excreted/secreted antigen form of 14-3-3 protein in Toxoplasma gondii tachyzoites. FEMS Microbiol. Lett. 2004, 234:19-25.
3. Baxter H.C., Liu W.G., Forster J.L., Aitken A., Fraser J.R. Immunolocalisation of 14-3-3 isoforms in normal and scrapie-infected murine brain. Neuroscience 2002, 109:5-14.
4. Beaver P.C., Rosen L. Memorandum on the first report of angiostrongylus in man, by Nomura and Lin, 1945. Am. J. Trop. Med. Hyg. 1964, 13:589-590.
5. Berg D., Holzmann C., Riess O. 14-3-3 proteins in the nervous system. Nat. Rev. Neurosci. 2003, 4:752-762.
6. Bonora S., Zanusso G., Raiteri R., Monaco S., Rossati A., Ferrari S., Boffito M., Audagnotto S., Sinicco A., Rizzuto N., Concia E., Di Perri G. Clearance of 14-3-3 protein from cerebrospinal fluid heralds the resolution of bacterial meningitis. Clin. Infect. Dis. 2003, 36:1492-1495.
7. Boston P.F., Jackson P., Thompson R.J. Human 14-3-3 protein: radioimmunoassay, tissue distribution, and cerebrospinal fluid levels in patients with neurological disorders. J. Neurochem. 1982, 38:1475-1482.
8. Chang E.E., Chung L.Y., Yen C.M. Kinetics of change in the eotaxin concentration in serum and cerebrospinal fluid of mice infected with Angiostrongylus cantonensis. Parasitol. Res. 2004, 92:137-141.
9. Chen K.M., Lee H.H., Lu K.H., Tseng Y.K., Hsu L.S., Chou H.L., Lai S.C. Association of matrix metalloproteinase-9 and Purkinje cell degeneration in mouse cerebellum caused by Angiostrongylus cantonensis. Int. J. Parasitol. 2004, 34:1147-1156.
10. Chotmongkol V., Sawanyawisuth K., Thavornpitak Y. Corticosteroid treatment of eosinophilic meningitis. Clin. Infect. Dis. 2000, 31:660-662.
11. Clutterbuck E.J., Sanderson C.J. Regulation of human eosinophil precursor production by cytokines: a comparison of recombinant human interleukin-1 (rhIL-1), rhIL-3, rhIL-5, rhIL-6, and rh granulocyte-macrophage colony-stimulating factor. Blood 1990, 75:1774-1779.
12. Collins S., Boyd A., Fletcher A., Gonzales M., McLean C.A., Byron K., Masters C.L. Creutzfeldt-Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid. J. Clin. Neurosci. 2000, 7:203-208.
13. Fu H., Subramanian R.R., Masters S.C. 14-3-3 proteins: structure, function, and regulation. Annu. Rev. Pharmacol. Toxicol. 2000, 40:617-647.
14. Haik S., Brandel J.P., Sazdovitch V., Delasnerie-Lauprêtre N., Peoc'h K., Laplanche J.L., Privat N., Duyckaerts C., Kemeny J.L., Kopp N., Laquerrière A., Mohr M., Deslys J.P., Dormont D., Hauw J.J. Dementia with Lewy bodies in a neuropathologic series of suspected Creutzfeldt-Jakob disease. Neurology 2000, 55:1401-1404.
15. Hsich G., Kenney K., Gibbs C.J., Lee K.H., Harrington M.G. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N. Engl. J. Med. 1996, 335:924-930.
16. Hu T.H., Huang C.C., Liu L.F., Lin P.R., Liu S.Y., Chang H.W., Changchien C.S., Lee C.M., Chuang J.H., Tai M.H. Expression of hepatoma-derived growth factor in hepatocellular carcinoma. Cancer 2003, 98:1444-1456.
17. Irani D.N., Kerr D.A. 14-3-3 protein in the cerebrospinal fluid of patients with acute transverse myelitis. Lancet 2000, 355:901.
18. John D.T., Martinez A.J. Animal model of human disease. Central nervous system infection with the nematode Angiostrongylus cantonenis. Animal model: eosinophilic meningoencephalitis in mice infected with Angiostrongylus cantonensis. Am. J. Pathol. 1975, 80:345-348.
19. Lee J.D., Tsai L.Y., Chen C.H., Wang J.J., Hsiao J.K., Yen C.M. Blood-brain barrier dysfunction occurring in mice infected with Angiostrongylus cantonensis. Acta Trop. 2006, 97:204-211.
20. Lopez A.F., Sanderson C.J., Gamble J.R., Campbell H.D., Young I.G., Vadas M.A. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 1988, 167:219-224.
21. Miller R.F., Green A.J.E., Giovannoni G., Thompson E.J. Detection of 14-3-3 brain protein in cerebrospinal fluid of HIV infected patients. Sex. Transm. Infect. 2000, 76:408.
22. Morassutti A.L., Levert K., Perelygin A., da Silva A.J., Wilkins P., Graeff-Teixeira C. The 31-kDa antigen of Angiostrongylus cantonensis comprises distinct antigenic glycoproteins. Vector Borne Zoonotic Dis. 2012, 12:961-968.
23. Nishimura K., Mogi M., Okazaw T. Angiostrongylus cantonensis infection in Ampullarium canaliculatus in Kyusu. Japan. Southeast Asian J. Trop. Med. Pub. Health 1986, 17:595-600.
24. Pien F.D., Pien B.C. Angiostrongylus cantonensis eosinophilic meningitis. Int. J. Infect. Dis. 1999, 3:161-163.
25. Punyagupta S., Juttijudata P., Bunnag T. Eosinophilic meningitis in Thailand. Clinical studies of 484 typical cases probably caused by Angiostrongylus cantonensis. Am. J. Trop. Med. Hyg. 1975, 24:921-931.
26. Richards C., Merritt J. Studies on Angiostrongylus cantonensis in molluscan intermediate hosts. J. Parasitol. 1967, 53:382-388.
27. Rosen L., Chappell R., Laqueur G. Eosinophilic meningoencephalitis caused by a metastrongylid lung worm of rats. JAMA 1962, 179:620-624.
28. Rosenberg G.A., DencoV J.E., Correa N., Reiners M., Ford C.C. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury. Neurology 1996, 46:1626-1632.
29. Rothenberg M.E. Eosinophilia. N. Engl. J. Med. 1998, 338:1592-1600.
30. Sawanyawisuth K., Limpawattana P., Busaracome P., Ninpaitoon B., Chotmongkol V., Intapan P.M., Tanawirattananit S. A 1-week course of corticosteroids in the treatment of eosinophilic meningitis. Am. J. Med. 2004, 117:802-803.
31. Schechtman D., Winnen R., Tarrab-Hazdai R., Ram D., Shinder V., Grevelding C.G., Kunz W., Arnon R. Expression and immunolocalization of the 14-3-3 protein of Schistosoma mansoni. Parasitology 2001, 123:573-582.
32. Siles-Lucas M., Merli M., Gottstein B. 14-3-3 proteins in Echinococcus: their role and potential as protective antigens. Exp. Parasitol. 2008, 119:516-523.
33. Toyooka K., Muratake T., Watanabe H., Hayashi S., Ichikawa T., Usui H., Washiyama K., Kumanishi T., Takahashi Y. Isolation and structure of the mouse 14-3-3 eta chain gene and the distribution of 14-3-3 eta mRNA in the mouse brain. Brain Res. Mol. Brain Res. 2002, 100:13-20.
34. Tsai H.C., Liu Y.C., Kunin C.M., Lee S.S., Chen Y.S., Lin H.H., Tsai T.H., Lin W.R., Huang C.K., Yen M.Y., Yen C.M. Eosinophilic meningitis caused by Angiostrongylus cantonensis: report of 17 cases. Am. J. Med. 2001, 111:109-114.
35. Tu W.C., Lai S.C. Angiostrongylus cantonensis: efficacy of albendazole-dexamethasone co-therapy against infection-induced plasminogen activators and eosinophilic meningitis. Exp. Parasitol. 2006, 113:8-15.
36. Wallace G.D., Rosen L. Experimental infection of Pacific Island mollusks with Angiostrongylus cantonensis. Am. J. Trop. Med. Hyg. 1969, 18:13-19.
37. Wang Q.P., Wu Z.D., Wei J., Owen R.L., Lun Z.R. Human Angiostrongylus cantonensis: an update. Eur. J. Clin. Microbiol. Infect. Dis. 2012, 31:389-395.
38. Wang Y., Cheng Z., Lu X., Tang C. Echinococcus multilocularis: Proteomic analysis of the protoscoleces by bi-dimensional electrophoresis and mass spectrometry. Exp. Parasitol. 2009, 123:162-167.
39. Wen Y. Distribution patterns of Angiostrongylus cantonensis in Achatina fulica. Chin. J. Microbiol. 1973, 6:1-10.
40. Yen C.M., Chen E.R., Cheng C.W. A survey of Ampullarium canaliculatus for natural infection of Angiostrongylus cantonensis in south Taiwan. J. Trop. Med. Hyg. 1990, 93:347-350.
41. Yii C.Y. Clinical observations on Eosinophilic Meningitis and Meningoencephalitis caused by Angiostrongylus Cantonensis on Taiwan. Am. J. Trop. Med. Hyg. 1976, 25:233-249.